MICHAEL SEVERINO - 16 May 2022 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Vice Chairman
Signature
Steven L. Scrogham, attorney-in-fact for Michael Severino
Issuer symbol
ABBV
Transactions as of
16 May 2022
Net transactions value
-$30,854,730
Form type
4
Filing time
18 May 2022, 17:12:28 UTC
Previous filing
16 May 2022
Next filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Options Exercise $4,349,135 +70,879 +47% $61.36 222,982 16 May 2022 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $2,301,141 +29,121 +13% $79.02 252,103 16 May 2022 Direct
transaction ABBV Common Stock, $0.01 par value Sale $7,127,893 -46,273 -18% $154.04 205,830 16 May 2022 Direct F1
transaction ABBV Common Stock, $0.01 par value Sale $8,255,020 -53,327 -26% $154.80 152,503 16 May 2022 Direct F2
transaction ABBV Common Stock, $0.01 par value Sale $62,176 -400 -0.26% $155.44 152,103 16 May 2022 Direct F3
transaction ABBV Common Stock, $0.01 par value Options Exercise $2,794,463 +35,364 +23% $79.02 187,467 17 May 2022 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $6,043,466 +64,636 +34% $93.50 252,103 17 May 2022 Direct
transaction ABBV Common Stock, $0.01 par value Sale $6,692,770 -43,621 -17% $153.43 208,482 17 May 2022 Direct F4
transaction ABBV Common Stock, $0.01 par value Sale $8,385,563 -54,279 -26% $154.49 154,203 17 May 2022 Direct F5
transaction ABBV Common Stock, $0.01 par value Sale $326,067 -2,100 -1.4% $155.27 152,103 17 May 2022 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to Buy) Options Exercise $4,349,135 -70,879 -100% $61.36 0 16 May 2022 Common Stock 70,879 $61.36 Direct F7
transaction ABBV Option (Right to Buy) Options Exercise $2,306,383 -29,121 -45% $79.20 35,364 16 May 2022 Common Stock 29,121 $79.02 Direct F7
transaction ABBV Option (Right to Buy) Options Exercise $2,794,463 -35,364 -100% $79.02 0 17 May 2022 Common Stock 35,364 $79.02 Direct F7
transaction ABBV Option (Right to Buy) Options Exercise $6,043,466 -64,636 -56% $93.50 49,930 17 May 2022 Common Stock 64,636 $93.50 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.38 to $154.37 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.38 to $154.81 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at a price of $155.44. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.95 to $153.92 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.02 to $155.00 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at a price of $155.27. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).